Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Past Issue Archives
Self-Assessment Questions
Review of
Clinical Signs
Clinical Review
Pediatric Rounds
Resident Grand Rounds
Article Archives
Case Reports
Clinical Practice
Pediatric Rounds
Resident Grand Rounds
Review of
Clinical Signs

Guide to Reading
Hospital Physician
Editorial Board
Information for Authors

Reprints, Permissions, & Copyright
Site Map
Self-Assessment Questions


Answer 2
  1. Quetiapine. Quetiapine, an atypical antipsychotic, is often used as a first-line agent for the treatment of drug-induced psychosis in Parkinson’s disease;3,4 however, there has been at least 1 negative study.5 Clozapine, another atypical antipsychotic, is also effective6 but carries the risk of serious adverse effects (eg, infection, agranulocytosis); thus, quetiapine may be a better first choice. Classic or “typical” antipsychotic agents, such as haloperidol, trifluoperazine, and thiothixene, worsen the motor symptoms of Parkinson’s disease and are not recommended for the treatment of drug-induced psychosis.

    3.  Molho ES, Factor SA. Parkinson’s disease: the treatment of drug-induced hallucinations and psychosis. Curr Neurol Neurosci Rep 2001;1:320-8.

    4. Juncos JL, Roberts VJ, Evatt ML, et al. Quetiapine improves psychotic symptoms and cognition in Parkinson’s disease. Mov Disord 2004;19:29-35.

    5. Ondo WG, Tintner R, Voung KD, et al. Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson’s disease. Mov Disord 2005;20:958-63.

Click here to return to the questions


Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2009, Turner White Communications
Updated 1/31/08 • kkj